Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Vlahov

Showing results (1-10 of 326) with videos related to

Pageof 33
Sort By:
AIDS (London, England)|February 1, 1994
HIV seroconversion studies among intravenous drug usersD Vlahov
NIDA Research Monograph|January 1, 1992
HIV-1 infection in the correctional settingD Vlahov
AIDS Research and Human Retroviruses|January 1, 1994
HIV vaccines for injection drug users in the context of a comprehensive prevention agendaD Vlahov
Seminars in Oncology Nursing|November 1, 1989
AIDS: overview, immunology, virology, and informational needsD Vlahov
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|September 1, 1995
Deregulation of the sale and possession of syringes for HIV prevention among injection drug usersD Vlahov
Lancet (London, England)|May 20, 1999
Controlled clinical evaluation of diacetyl morphine for treatment of intractable opiate dependenceE Drucker, D Vlahov
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Why don't intravenous drug users use condoms?C Jones, D Vlahov
Public Health Reports (Washington, D.C. : 1974)|December 16, 1998
The role of needle exchange programs in HIV preventionD Vlahov, B Junge
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|July 15, 1998
Use of sterile syringes and aseptic drug preparation are important components of HIV prevention among injection drug usersT S Jones, D Vlahov
Addiction (Abingdon, England)|November 14, 1998
Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug usersC A Latkin, D Vlahov
Pageof 33

Showing results (1-10 of 326) with videos related to

Sort By:
Pageof 33
AIDS (London, England)|February 1, 1994
HIV seroconversion studies among intravenous drug usersD Vlahov
NIDA Research Monograph|January 1, 1992
HIV-1 infection in the correctional settingD Vlahov
AIDS Research and Human Retroviruses|January 1, 1994
HIV vaccines for injection drug users in the context of a comprehensive prevention agendaD Vlahov
Seminars in Oncology Nursing|November 1, 1989
AIDS: overview, immunology, virology, and informational needsD Vlahov
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|September 1, 1995
Deregulation of the sale and possession of syringes for HIV prevention among injection drug usersD Vlahov
Lancet (London, England)|May 20, 1999
Controlled clinical evaluation of diacetyl morphine for treatment of intractable opiate dependenceE Drucker, D Vlahov
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Why don't intravenous drug users use condoms?C Jones, D Vlahov
Public Health Reports (Washington, D.C. : 1974)|December 16, 1998
The role of needle exchange programs in HIV preventionD Vlahov, B Junge
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|July 15, 1998
Use of sterile syringes and aseptic drug preparation are important components of HIV prevention among injection drug usersT S Jones, D Vlahov
Addiction (Abingdon, England)|November 14, 1998
Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug usersC A Latkin, D Vlahov
Pageof 33